Dynavax Technologies

HEPLISAV-B

Manufacturer:

Dynavax Technologies

Heplisav-B HCPCS:

90739

HCPCS Code Descriptor:

Hep B Vaccine Adult Dosage (2-Dose schedule) for IM Use

Category:

CPT Drug Code

Heplisav-B NDCs:

43528-0003-05

Primary Type:

Vaccine-Hepatitis B

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Heplisav-B CPT Codes:

Potential CPT administration codes for Heplisav-B can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Heplisav-B:

HEPLISAV-B is a Vaccine-Hepatitis B drug manufactured by Dynavax Technologies and administered via the Intramuscular route of administration. The CPT Drug Code: 90739 is aligned to the drug HEPLISAV-B.

ACCESS PRICING AND MORE BY REGISTERING

90739 Added Date:

NA

90739 Effective Date:

NA

90739 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Heplisav-B billing and coding information.
Our team did not identify a source for Heplisav-B patient assistance information. Please reach out to our team if you feel that this is a mistake.
HEPLISAV-B prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for HEPLISAV-B. Please check back in a few weeks.

BuyandBill.com Drug Alert: